155 related articles for article (PubMed ID: 19493919)
21. Malignant mesothelioma of the tunica vaginalis testis: a case with a predominant sarcomatous component.
Shimada S; Ono K; Suzuki Y; Mori N
Pathol Int; 2004 Dec; 54(12):930-4. PubMed ID: 15598316
[TBL] [Abstract][Full Text] [Related]
22. Well-differentiated papillary mesothelioma of the tunica vaginalis: a case report with aspirate cytologic, immunohistochemical, and ultrastructural studies.
Fukunaga M
Pathol Res Pract; 2010 Feb; 206(2):105-9. PubMed ID: 19285812
[TBL] [Abstract][Full Text] [Related]
23. A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma.
Zafar R; Schrader LJ; Cheville JC; Schoolmeester JK; Roden AC; Aubry MC; Yi ES; Raghunathan A; Herrera-Hernandez L; Thompson RH; Boorjian SA; Leibovich BC; Keeney GL; Jimenez RE; Gupta S
Hum Pathol; 2022 Oct; 128():31-47. PubMed ID: 35809685
[TBL] [Abstract][Full Text] [Related]
24. Paratesticular mesothelioma. Report of a case with comprehensive review of literature.
Bisceglia M; Dor DB; Carosi I; Vairo M; Pasquinelli G
Adv Anat Pathol; 2010 Jan; 17(1):53-70. PubMed ID: 20032640
[TBL] [Abstract][Full Text] [Related]
25. Malignant mesothelioma of the tunica vaginalis.
Kamiya M; Eimoto T
Pathol Res Pract; 1990 Oct; 186(5):680-4; discussion 685-6. PubMed ID: 2287593
[TBL] [Abstract][Full Text] [Related]
26. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
27. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases.
Malpica A; Sant'Ambrogio S; Deavers MT; Silva EG
Am J Surg Pathol; 2012 Jan; 36(1):117-27. PubMed ID: 22024662
[TBL] [Abstract][Full Text] [Related]
28. Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.
Ordóñez NG
Hum Pathol; 2005 Nov; 36(11):1163-7. PubMed ID: 16260268
[TBL] [Abstract][Full Text] [Related]
29. Well-Differentiated Papillary Mesothelioma with Omental Calcifications: A Case Report and Review of the Literature.
Erem AS; Allamaneni SS; Braverman TS
Am J Case Rep; 2020 Jan; 21():e920487. PubMed ID: 31929500
[TBL] [Abstract][Full Text] [Related]
30. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
[TBL] [Abstract][Full Text] [Related]
31. [A case of benign mesothelioma of the tunica vaginalis testis].
Fujii Y; Masuda M; Hirokawa M; Matsushita K; Asakura S
Hinyokika Kiyo; 1993 Jan; 39(1):89-92. PubMed ID: 8460596
[TBL] [Abstract][Full Text] [Related]
32. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
[TBL] [Abstract][Full Text] [Related]
33. Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
Kawai T; Tominaga S; Hiroi S; Ogata S; Nakanishi K; Kawahara K; Sonobe H; Hiroshima K
J Clin Pathol; 2016 Aug; 69(8):706-12. PubMed ID: 26729015
[TBL] [Abstract][Full Text] [Related]
34. Borderline serous papillary tumour of the testis: a case report and review of the literature.
Ibrahim AS; Li C; Al-Jafari MS
Anticancer Res; 2012 Nov; 32(11):5011-3. PubMed ID: 23155272
[TBL] [Abstract][Full Text] [Related]
35. Papillary serous carcinoma of ovarian type of the testis with borderline differentiation.
Guarch R; Rivas A; Puras A; Pesce C
Histopathology; 2005 May; 46(5):588-90. PubMed ID: 15842644
[No Abstract] [Full Text] [Related]
36. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.
Kushitani K; Takeshima Y; Amatya VJ; Furonaka O; Sakatani A; Inai K
Pathol Int; 2007 Apr; 57(4):190-9. PubMed ID: 17316414
[TBL] [Abstract][Full Text] [Related]
37. Malignant mesothelioma of the tunica vaginalis.
Al-Qahtani M; Morris B; Dawood S; Onerheim R
Can J Urol; 2007 Apr; 14(2):3514-7. PubMed ID: 17466159
[TBL] [Abstract][Full Text] [Related]
38. Well-differentiated papillary mesothelioma occurring in the tunica vaginalis of the testis with contralateral atypical mesothelial hyperplasia.
Tolhurst SR; Lotan T; Rapp DE; Lyon MB; Orvieto MA; Gerber GS; Sokoloff MH
Urol Oncol; 2006; 24(1):36-9. PubMed ID: 16414491
[TBL] [Abstract][Full Text] [Related]
39. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
Duggan MA; Masters CB; Alexander F
Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
